Prescribe Right
Prescribe Right
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • COVID-19
    • COVID-19 Updates
    • COVID-19 Vaccines
    • COVID-19 Antivirals
    • COVID-19 Monoclonal Antibodies
    • COVID-19 Plasma Products
    • COVID-19 Anti-Inflammatories
    • Remdesivir
    • Ivermectin
  • Subscription Offers
  • Contact
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • COVID-19
    • COVID-19 Updates
    • COVID-19 Vaccines
    • COVID-19 Antivirals
    • COVID-19 Monoclonal Antibodies
    • COVID-19 Plasma Products
    • COVID-19 Anti-Inflammatories
    • Remdesivir
    • Ivermectin
  • Subscription Offers
  • Contact
Pipeline News and Updates
Picture

New Drugs Added to Knowledgebase

4/5/2022

 
Last week we added 15 new drugs to the knowledgebase:
  • Dovitinib a tyrosine kinase inhibitor for the treatment of renal cell carcinoma
  • Stenoparib a PARP and Tankyrase inhibitor for the treatment of ovarian cancer
  • CLN-081 an epidermal growth factor (EGFR) tyrosine kinase inhibitor (TKI) inhibitor for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor (EGFR) exon 20 insertion mutations
  • AT-007 an aldose reductase inhibitor for the treatment of Galactosemia sorbitol dehydrogenase (SORD) deficiency and phosphomannomutase 2 deficiency
  • Efanesoctocog alfa a recombinant factor VIII therapy for the treatment of hemophilia A
  • Cefepime-taniborbactam a monobactam/beta-lactamasde inhibitor for the treatment of complicated urinary tract infection (UTI)
  • CAP-1002 a cardiosphere-derived cell therapy for the treatment of Duchenne Muscular Dystrophy
  • Telisotuzumab vedotin (teliso-V) an antibody drug conjugate (ADC) for the treatment of advanced or metastatic EGFR wild-type, nonsquamous non–small cell lung cancer (NSCLC) who have high levels of c-Met overexpression
  • Zandelisib a phosphatidylinositol-3-kinase (PI3K) inhibitor for the treatment of follicular lymphoma, marginal zone lymphoma
  • Enobosarm a non-steroidal, selective androgen receptor agonist, for the treatment of androgen receptor (AR)–positive, estrogen receptor (ER)–positive, HER2-negative, metastatic breast cancer 
  • Futibatinib a tyrosine kinase inhibitor for the treatment of metastatic cholangiocarcinoma harboring FGFR2 gene rearrangements, including gene fusions
  • Gedatolisib a PI3K and mTOR inhibitor for the treatment of hormone receptor–positive, HER2-negative metastatic breast cancer who experienced disease progression on CDK4/6 therapy
  • Adagrasib a KRAS inhibitor for the treatment of KRASG12C-mutated solid tumors, non-small cell lung cancer (NSCLC)
  • MB-207 a gene therapy for the treatment of X-linked severe combined immunodeficiency (SCID-X1)
  • CAP-1002 an allogeneic cardiosphere-derived cells therapy of the treatment of Duchenne Muscular Dystrophy
The Prescribe Right Pharmaceutical Pipeline Tracker now allows you to track 980 pipeline and recently approved drugs supported by 2,364 announced and published study results.

Comments are closed.
    Stay informed, subscribe to the 
    ​
    Prescribe Right Pharmaceutical Pipeline Tracker
    Latest Tweets from Prescribe Right

    Archives

    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    August 2015

    RSS Feed

Services

Pharmaceutical Pipeline Tracker​
Consulting

Company

About
Blog
Tweets

Support

Contact
© COPYRIGHT 2015. ALL RIGHTS RESERVED.